Patent application number | Description | Published |
20110085643 | Radiation therapy inverse treatment planning using a regularization of sparse segments - A method of reducing a total number of beam segments in a dose distribution for a radiation therapy field is provided. The method includes providing a multiobjective radiation therapy treatment plan using a suitably programmed computer, where the multiobjective radiation therapy treatment plan includes a radiation beam dose performance objective and a fluence map sparsity objective in a given fluence function domain, and providing a Pareto frontier of tradeoff criteria between the beam dose performance and a total number of radiation segments (or sub-fields) of the multiobjective radiation therapy treatment plan using the suitably programmed computer, where an achieved set of radiation beam dose distributions associated with efficiency points of the Pareto frontier are evaluated using a clinical acceptance criteria, where a clinically acceptable radiation beam dose distribution having a smallest number of the multileaf collimator segments is a final solution for the multiobjective radiation therapy treatment plan. | 04-14-2011 |
20120263360 | SCATTER CORRECTION METHODS - Described herein are improved methods for correcting cone beam computed tomography signals to reduce scatter contamination contained therein. Generally, the improved methods involve generating a plurality of two-dimensional projection images of a subject from a three-dimensional multi-detector computed tomography image of the subject. This is followed by subtracting the plurality of two-dimensional projection images from a plurality of two-dimensional cone beam projection images of the subject to produce a plurality of two-dimensional estimated error projections that comprise an estimated error in the plurality of two-dimensional cone beam projection images. The plurality of two-dimensional estimated error projection images are subtracted from the plurality of two-dimensional cone beam projection images to generate a plurality of two-dimensional corrected cone beam projection images. A three-dimensional corrected cone beam computed tomography image of the subject is then constructed from the plurality of two-dimensional corrected cone beam projection images. | 10-18-2012 |
20150231410 | METHODS, SYSTEMS AND COMPUTER READABLE STORAGE MEDIA FOR DETERMINING OPTIMAL RESPIRATORY PHASE FOR TREATMENT - Methods, systems and computer-readable storage media relate to determining optimal treatment information. The methods may include determining a dose distribution for one or more target regions by applying a deformation parameter to a treatment plan dose distribution for a subset of a plurality of phases. The method may also include determining one or more dose parameters based on the dose distribution for the subset of the plurality of phases. The one or more dose parameters may represent a motion of the dose distribution over the plurality of phases for each region. The method may further include determining optimal treatment information based on the one or more dose parameters. The optimal treatment information may include optimal phase and associated dose distribution and the optimal phase may be a phase having a minimum total dose for the one or more target regions. | 08-20-2015 |
Patent application number | Description | Published |
20090047687 | Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation - This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation. | 02-19-2009 |
20090197795 | PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY - This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 08-06-2009 |
20090253762 | PREPARATION AND USE OF ARYL ALKYL ACID DERIVATIVES FOR THE TREATMENT OF OBESITY - This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 10-08-2009 |
20090270468 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity - This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 10-29-2009 |
20110065129 | INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION - This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation. | 03-17-2011 |
20110152330 | INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION - This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation. | 06-23-2011 |
20110152331 | INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION - This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation. | 06-23-2011 |
Patent application number | Description | Published |
20090060908 | Monoclonal Antibodies Against Prostate Specific Membrane Antigen (PSMA) Lacking in Fucosyl Residues - The invention pertains to anti-PSMA antibodies that lack fucosyl residues. The antibodies of the invention exhibit increased antibody-dependent cellular cytotoxicity (ADCC) activity as compared to the fucosylated form of the antibodies. The invention also provides host cells that express the anti-PSMA antibodies that lack fucosyl residues, wherein the host cells are deficient for a fucosyl transferase. Methods of using the antibodies to inhibit the growth of PSMA+ cells, such as tumor cells, are also provided. | 03-05-2009 |
20110028696 | MONOCLONAL ANTIBODIES AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LACKING IN FUCOSYL RESIDUES - The invention pertains to anti-PSMA antibodies that lack fucosyl residues. The antibodies of the invention exhibit increased antibody-dependent cellular cytotoxicity (ADCC) activity as compared to the fucosylated form of the antibodies. The invention also provides host cells that express the anti-PSMA antibodies that lack fucosyl residues, wherein the host cells are deficient for a fucosyl transferase. Methods of using the antibodies to inhibit the growth of PSMA | 02-03-2011 |
20130023653 | Tissue Specific Expression Of Antibodies In Chickens - Transgenes encoding exogenous antibodies are stably integrated into donor cells and are present in the somatic tissue of chimeric birds. The transgenes encode exogenous antibodies and are preferably expressed in the oviduct for collection in the egg. Tissue specificity is provided by selecting the content of the transgene accordingly. Birds whose genome is comprised of trangene-derived exogenous antibody-encoding DNA express exogenous antibodies having desirable chemical properties with increased therapeutic utility compared to antibodies derived from bacterial expression systems. | 01-24-2013 |
20140329996 | TISSUE SPECIFIC EXPRESSION OF ANTIBODIES IN CHICKENS - Transgenes encoding exogenous antibodies are stably integrated into donor cells and are present in the somatic tissue of chimeric birds. The transgenes encode exogenous antibodies and are preferably expressed in the oviduct for collection in the egg. Tissue specificity is provided by selecting the content of the transgene accordingly. Birds whose genome is comprised of transgene-derived exogenous antibody-encoding DNA express exogenous antibodies having desirable chemical properties with increased therapeutic utility compared to antibodies derived from bacterial expression systems. | 11-06-2014 |
Patent application number | Description | Published |
20090083871 | Targeting constructs for the functional disruption of avian immunoglobulin genes - A transgenic chicken is disclosed having disrupted endogenous immunoglobulin production. In one embodiment, a targeting construct is stably integrated into the genome of the chicken by homologous recombination in embryonic stem cells, and injection of the engineered embryonic stem cells into recipient embryos, thereby knocking out the endogenous immunoglobulin gene locus in resulting animals. The targeted disruption of the locus in embryonic stem cells is particularly useful in combination with the insertion of genetic elements encoding exogenous immunoglobulin molecules. After these chickens are cross-bred, a line of chickens is produced that has a reduction of endogenous immunoglobulin molecule production. | 03-26-2009 |
20090165155 | Tissue Specific Expression of Exogenous Proteins in Transgenic Chickens - Transgenes encoding exogenous proteins are stably integrated into embryonic stem cells and are present in the somatic tissue of transgenic or chimeric birds. The transgenes encode exogenous proteins and are expressed in any of endodermal, ectodermal, mesodermal, or extra embryonic tissue. Tissue specificity is provided by selecting the content of the transgene accordingly. Transgenic birds whose genome is comprised of trangene derived exogenous DNA express exogenous proteins with tissue specificity, and specifically express exogenous proteins in the tubular gland cells of the oviduct to concentrate exogenous proteins in egg white. | 06-25-2009 |
20110023160 | Functional Disruption Of Avian Immunoglobulin Genes - A transgenic chicken is disclosed having disrupted endogenous immunoglobulin production. In one embodiment, a targeting construct is stably integrated into the genome of the chicken by homologous recombination in embryonic stem cells, and injection of the engineered embryonic stem cells into recipient embryos, thereby knocking out the endogenous immunoglobulin gene locus in resulting animals. The targeted disruption of the locus in embryonic stem cells is particularly useful in combination with the insertion of genetic elements encoding exogenous immunoglobulin molecules. After these chickens are cross-bred, a line of chickens is produced that has a reduction of endogenous immunoglobulin molecule production. | 01-27-2011 |
20110277048 | Transgenic Aves Producing Human Polyclonal Antibodies - Human antibodies are produced in transgenic chickens having functional genetic components of the human immune system stably integrated in the genome. Techniques are described to integrate unrearranged human heavy and light chain immunoglobulin loci into the genome of the transgenic chicken. | 11-10-2011 |
20120156771 | FUNCTIONAL DISRUPTION OF AN IMMUNOGLOBULIN GENE IN AN AVIAN EMBRYONIC STEM CELL - A transgenic chicken is disclosed having disrupted endogenous immunoglobulin production. In one embodiment, a targeting construct is stably integrated into the genome of the chicken by homologous recombination in embryonic stem cells, and injection of the engineered embryonic stem cells into recipient embryos, thereby knocking out the endogenous immunoglobulin gene locus in resulting animals. The targeted disruption of the locus in embryonic stem cells is particularly useful in combination with the insertion of genetic elements encoding exogenous immunoglobulin molecules. After these chickens are cross-bred, a line of chickens is produced that has a reduction of endogenous immunoglobulin molecule production. | 06-21-2012 |
20140155580 | TRANSGENIC AVES PRODUCING HUMAN POLYCLONAL ANTIBODIES - Human antibodies are produced in transgenic chickens having functional genetic components of the human immune system stably integrated in the genome. Techniques are described to integrate unrearranged human heavy and light chain immunoglobulin loci into the genome of the transgenic chicken. | 06-05-2014 |
Patent application number | Description | Published |
20110003739 | AZINONE-SUBSTITUTED AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF - Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention. | 01-06-2011 |
20110306605 | COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND CANCER - Compounds including those of the Formula I | 12-15-2011 |
20120035102 | AZINONE-SUBSTITUTED AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF - Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention. | 02-09-2012 |
20130158017 | METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES - Provided are methods of treating or preventing a neurodegenerative disease comprising administering to a subject having a neurodegenerative disease an effective amount of a compound of Formula I: | 06-20-2013 |
20150119362 | HETEROARYL INHIBITORS OF PDE4 - The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease. | 04-30-2015 |
20150133493 | COUMARIN-BASED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND CANCER - Compounds including those of the Formula I | 05-14-2015 |
20150272962 | METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES - Provided are methods of treating or preventing a neurodegenerative disease comprising administering to a subject having a neurodegenerative disease an effective amount of a compound of Formula I: | 10-01-2015 |
Patent application number | Description | Published |
20090036678 | Process for the synthesis of E1 activating enzyme inhibitors - The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((1S,2S,4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity. | 02-05-2009 |
20110155171 | Cleaning and Conditioning Cloth - A cleaning and conditioning cloth for an ice skate, including hockey and speed skates, as well as other objects, includes a rectangular body, or a body selected from one of other various shapes such as circle, square, and diamond, of cut-resistant, water-absorbent fabric and an oil impregnated fabric affixed to the approximate center of the cleaning and conditioning cloth body wherein the method includes the steps of holding the cleaning and conditioning cloth in one hand and the ice skate in the other, placing the blade of the ice skate in the middle of the oil impregnated fabric, and moving the ice skate and the cleaning and conditioning cloth relative to each other, so that the blade moves from the cleaning and conditioning cloth body to the oil impregnated fabric. The body and the oil impregnated fabric may be of various sizes. | 06-30-2011 |
20120291802 | MULTI-USE CLEANING AND CONDITIONING CLOTH - A multi-use cloth for cleaning and conditioning metal and non-metal objects includes a two-layer, three-layer or multi-layer structure. Each layer is made of material either capable of retaining an oil, aqueous solution, aqueous suspension or solid or capable of preventing penetration of an oil, aqueous solution, aqueous suspension or solid. In a three-layer or multi-layer cloth, the separation layer is affixed in between two layers having one or both layers embedded with an oil, aqueous solution, or aqueous suspension. In a two-layer cloth, the separation layer is affixed to one side of the layer that is embedded with an oil, aqueous solution or an aqueous suspension. The cloth is folded with the oil, or aqueous solution, or aqueous suspension embedded side on an inner side. A user's hand holds the outside of the cloth and no contamination from oil, aqueous solution, or aqueous suspension or solid occurs. | 11-22-2012 |
20150080573 | PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS - The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((1S,2S,4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity. | 03-19-2015 |
20150175542 | THIOLACTAMS AND USES THEREOF - This invention provides compounds of formula I: | 06-25-2015 |
20150353555 | PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS - The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((1S,2S,4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity. | 12-10-2015 |
Patent application number | Description | Published |
20120093113 | METHOD AND APPARATUS FOR REDUCING DELAY IN ESTABLISHING SESSION - Embodiments of the present invention disclose a method and an apparatus for reducing a delay in establishing a session, relating to the field of communication technologies. The method for reducing a delay in establishing a session includes: sending a measurement report to a network control device after establishing a connection with the network control device; receiving a radio bearer reconfiguration message sent by the network control device and performing state transition to a CELL_DCH state; sending a radio bearer reconfiguration confirmation message to the network control device to notify the network control device that the state transition is completed; and receiving a session confirmation message sent by the network control device to enter into a session state. | 04-19-2012 |
20120155375 | Method and Apparatus for Header Compression in Network Relay Scenario - Embodiments of the present application disclose a method and an apparatus for header compression in a network relay scenario. The method includes: receiving, by a relay node, a first header-compressed data packet sent by user equipment or another relay node; encapsulating a transport protocol header for the first data packet and performing header compression for the header to form a second data packet; and sending the second data packet to an eNodeB or a next relay node in an uplink direction. | 06-21-2012 |
20120294211 | METHOD AND APPARATUS FOR COMPRESSING NESTED PROTOCOL PACKET HEADER - Embodiments of the present invention disclose a method for compressing a nested protocol packet header, which relate to the field of wireless communication technologies and are used to improve efficiency in compressing a nested protocol packet header in a data packet. The method for compressing a nested protocol packet header provided in the embodiments of the present invention includes: receiving a data packet sent by at least one sending end, where the data packet includes a first compression protocol packet header; taking the received data packet as a whole and nesting a second protocol packet header in it; and processing the data packet nested with the second protocol packet header, where the processing includes: coordinating part of function fields in the first compression protocol packet header and the second protocol packet header to remove a duplicate field, and compressing the second protocol packet header; and sending the processed data packet. | 11-22-2012 |
20120307634 | METHOD FOR HANDLING LOCAL LINK CONGESTION AND APPARATUS - The present invention relates to the field of congestion control, and discloses a method for handling local link congestion and an apparatus. The method includes: negotiating, by a local link control entity, a local congestion notification capability with a local terminal; setting, by the local link control entity, a congestion identifier in a downlink data packet corresponding to the local congestion notification capability when a local link is congested between the local link control entity and the local terminal; and performing, by the local link control entity, congestion control on the local link, or performing, by the local terminal, congestion control on the local link according to the congestion identifier. The apparatus includes a local link control entity and a terminal device. | 12-06-2012 |
20140269584 | METHOD AND DEVICE FOR IMPROVING CELL THROUGHPUT BASED ON STREAMING MEDIA SERVICE - Embodiments of the present invention provide a method and a system for improving a cell throughput based on a streaming media service. The method includes: pre-adjusting, according to a channel quality sampling value of two clients in the same cell that are performing a streaming media service, an air interface resource allocated to the two clients; acquiring a variation of a cell throughput that exists after the air interface resources of the two clients are pre-adjusted; and if the variation of the cell throughput that exists after the air interface resources of the two clients are pre-adjusted is greater than a preset resource adjustment threshold, allocating the pre-adjusted air interface resources to the two clients, so that the two clients two capable of receiving streaming media content having an adjusted code rate value from a media server. | 09-18-2014 |
20150135193 | STREAMING EVENT DATA COLLECTION - Methods, systems, and apparatus, including computer programs encoded on computer storage media, for distributed data management. One of the methods includes receiving a plurality of feeds of streaming event data and routing feed data from each of the feeds to a respective channel of a plurality of channels, each of the channels being configured to store feed data until the feed data is consumed by a data sink, including routing feed data from a first feed to a first channel. A load metric for the first channel is determined to exceed a threshold. In response, a second channel is allocated for the first feed and feed data is redirected from the first feed to the second channel instead of the first channel. | 05-14-2015 |
20150138982 | Policy Control Method, and Device - Embodiments of the present invention provide a policy control method and a device. The method includes: receiving a quality of experience QoE report sent by a user equipment UE, where the QoE report includes a QoE metric and a cell identity of a serving cell of the UE; and performing cell policy control according to the QoE report. In the embodiments of the present invention, a QoE server receives a QoE report sent by a UE, where the QoE report not only includes a QoE metric, but also includes a cell identity of a serving cell of the UE. Therefore, the QoE server performs policy control within a cell range according to the QoE report, thereby effectively improving flexibility of QoE service deployment and enhancing user experience. | 05-21-2015 |
20150345709 | LIQUID SUPPLYING DEVICE AND PHOTORESIST COATING EQUIPMENT - The present invention provides a liquid supplying device and a photoresist coating equipment. The liquid supplying device i A liquid supplying device, comprising: a tank for storing liquid; and a liquid transfer pipe inserted into the tank, and an elastic retractable structure is provided on at least one portion of the liquid transfer pipe, and a pipe end portion of the liquid transfer pipe in the tank is always contacted with and pressed against an inner wall of the tank. In the present invention, the liquid is able to be output continuously, and a problem of the prior art in which the liquid stored in the tank cannot be used sufficiently can be avoided. | 12-03-2015 |
Patent application number | Description | Published |
20130126941 | SEMICONDUCTOR OPTICAL DEVICE - A semiconductor optical device includes a first clad layer, a second clad layer and an optical waveguide layer sandwiched between the first clad layer and the second clad layer, wherein the optical waveguide layer includes a first semiconductor layer, a second semiconductor layer disposed on the first semiconductor layer and extending in one direction, and a third semiconductor layer covering a top surface of the second semiconductor layer, and wherein the first semiconductor layer includes an n-type region disposed on one side of the second semiconductor layer, a p-type region disposed on the other side of the second semiconductor layer, and an i-type region disposed between the n-type region and the p-type region, and wherein the second semiconductor layer has a band gap narrower than band gaps of the first semiconductor layer and the third semiconductor layer. | 05-23-2013 |
20130337619 | COMPOUND SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME - A compound semiconductor device includes: a compound semiconductor region having a surface in which a step is formed; a first electrode formed so as to overlie the upper surface of the step, the upper surface being a non-polar face; and a second electrode formed along a side surface of the step so as to be spaced apart from the first electrode in a vertical direction, the side surface being a polar face. | 12-19-2013 |
20140084344 | COMPOUND SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME - A compound semiconductor device includes: an electron transit layer formed of a compound semiconductor; and an electrode formed so as to overlie the electron transit layer with an insulating film interposed between the electron transit layer and the electrode, wherein part of the electron transit layer below the electrode are formed such that a first compound semiconductor having a first polar face and a second compound semiconductor having a second polar face are alternately arranged, and polarization charges in the first polar face have opposite polarity to polarization charges in the second polar face. | 03-27-2014 |
20150194512 | SEMICONDUCTOR DEVICE - A semiconductor device includes: a first semiconductor layer which is formed over a substrate and is formed from a nitride semiconductor; a second semiconductor layer which is formed over the first semiconductor layer and is formed from a nitride semiconductor; a third semiconductor layer which is formed over the second semiconductor layer and is formed from a nitride semiconductor; a source electrode and a drain electrode which are formed over the third semiconductor layer; an opening which is formed in the second semiconductor layer and the third semiconductor layer between the source electrode and the drain electrode; an insulating layer which is formed on a side surface and a bottom surface of the opening; and a gate electrode which is formed in the opening through the insulating layer. | 07-09-2015 |
Patent application number | Description | Published |
20140303779 | CONTROL SYSTEM FOR MAGNETIC BEARINGS IN A CENTRIFUGAL GAS COMPRESSOR - A control system and method of control for a centrifugal gas compressor including a magnetic bearing. The control system and method is configured to control the operation of a magnetic bearing system, and may control other systems of the gas compressor as well. Bearing communications are digitized proximate the gas compressor and communicated using data packet communications. The compressor and magnetic bearing controls may be performed on the same computer, and the control systems of the compressor, magnetic bearing, and engine or motor can all share information, a common user interface, and a common uninterrupted power source. | 10-09-2014 |
20140303780 | METHOD FOR CONTROLLING A GAS COMPRESSOR HAVING A MAGNETIC BEARING - A method for controlling a gas compressor having a magnetic bearing. The method includes communicating digital feedback data from a magnetic bearing system to a computer via a communication link, processing the feedback data with the computer and issuing a bearing control command in response to the feedback data, communicating the bearing control command from the computer to the magnetic bearing system via a communication link, providing operational processing and control of the gas compressor with the computer, and providing operational processing and control of the compressor driver with the computer. | 10-09-2014 |
20150285242 | CONTROLLING A GAS COMPRESSOR HAVING MULTIPLE MAGNETIC BEARINGS - A method for controlling a gas compressor is disclosed. The method includes communicating feedback data about two magnetic bearings to a computer including a multi-core processor via a communication link. The method also includes processing the feedback data about the two magnetic bearings where the feedback data for each of the two magnetic bearings is processed on separate cores of the multi-core processor in parallel and issuing a bearing control command to each of the two magnetic bearings in response to the feedback data. The method further includes communicating the bearing control commands to the two magnetic bearings from the computer via the communication link. | 10-08-2015 |
20150285253 | PENETRATOR POWER CONNECTOR FOR AN INTEGRATED ROTARY MACHINE - A power connector for an electric motor is disclosed. The power connector includes a flange, a conductor rod, and an insulation sleeve. The conductor rod includes a first portion extending in a first direction from the flange and a second portion extending from the flange in a second direction, opposite the first direction. The second portion includes a lead wire connection end distal to the flange. The insulation sleeve covers the second portion from the flange to the lead wire connection end. The insulation sleeve includes a sleeve outer surface, and a sealing rib extending outward from the sleeve outer surface. | 10-08-2015 |
20150288231 | ELECTRIC MOTOR WITH SYMMETRIC COOLING - An electric motor for a rotary machine is disclosed. The electric motor includes a first lamination section and a second lamination section radially spaced apart from a driver shaft forming a first air gap and a second air gap respectively. The second lamination section is axially spaced apart from the first lamination section forming an air gap cooling outlet there between. The electric motor also includes motor windings extending through the first lamination section and the second lamination section, and across the air gap cooling outlet in circumferential groups. A winding shield is located around each of the circumferential groups of the motor windings. | 10-08-2015 |
Patent application number | Description | Published |
20150315197 | SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE - The present invention provides a compound having the structure: | 11-05-2015 |
20160024007 | OCTAHYDROCYCLOPENTAPYRROLES, THEIR PREPARATION AND USE - The present invention provides Octahydrocyclopentapyrrole compounds having the structure: (structurally represented) wherein psi is absent or present, and when present is a bond; R1, R2, R3, R4, and R5 are each independently H, halogen, CF, or C1-C4 alkyl; R6 is absent or present, and when present is H, OH, or halogen; A is absent or present, and when present is C(O) or C(O)NH; B is substituted or unsubstituted monocycle, bicycle, heteromonocycle, heterobicycle, benzyl, CO2H or (C1-C4 alkyl)-CO2H, wherein when B is CO2H, then A is present and is C(O); and when psi is present, then R6 is absent and when psi is absent, then R6 is present, or a pharmaceutically acceptable salt thereof, for treatment of diseases characterized by excessive lipofuscin accumulation in the retina. | 01-28-2016 |